Jennifer Davis Ruff is a senior investor relations and corporate communications professional with over 20 years of experience in the biopharmaceutical and biotechnology industries. Currently, they serve as Vice President, Head of Investor Relations & Corporate Affairs at Dianthus Therapeutics, Inc. and have held previous executive roles at companies such as TESARO, Inc. and Pfizer. Jennifer received the 2018 Institutional Investor All-America Executive Team award for their outstanding work in biotechnology investor relations. They are pursuing a Master of Science degree at Northwestern University and hold a Bachelor of Arts degree from the University of Iowa.
This person is not in any offices